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Abstract
Background: Synthetic GCs serve as therapeutic agents for some lymphoid leukemias because of their ability to
induce transcriptional changes via the GC receptor (GR) and trigger apoptosis. Upregulation of the BH3-only
member of Bcl-2 family proteins, Bim, has been shown to be essential for GC-evoked apoptosis of leukemic
lymphoblasts. Using human T cell leukemic sister clones CEM-C7-14 and CEM-C1-15, we have previously shown
that the bZIP transcriptional repressor, E4BP4, is preferentially upregulated by GCs in CEM-C7-14 cells that are
susceptible to GC-evoked apoptosis, but not in refractory CEM-C1-15 cells. E4BP4 is an evolutionarily conserved
member of the PAR family of bZIP transcription factors related to the C. elegans death specification gene ces2.
Results: Mouse E4BP4 was ectopically expressed in CEM-C1-15 cells, resulting in sensitization to GC-evoked
apoptosis in correlation with restoration of E4BP4 and Bim upregulation. shRNA mediated modest knockdown of
E4BP4 in CEM-C7-14 cells resulted in concomitant reduction in Bim expression, although GC-evoked fold-induction
and sensitivity to apoptosis was similar to parental cells.
Conclusion: Data presented here suggest that GC-mediated upregulation of E4BP4 facilitates Bim upregulation and
apoptosis of CEM cells. Since the Bim promoter does not contain any consensus GRE or EBPRE sequences,
induction of Bim may be a secondary response.
Background
Glucocorticoids (GCs) are known to evoke human lym-
phoid cell apoptosis [1-3] primarily by binding to and
modulating the transcriptional activity of the GC recep-
tor (GR) [4]. GCs possess immunosuppressive and anti-
inflammatory properties and serve as effective therapeu-
tic agents for different forms of leukemia [5], asthma,
rheumatoid arthritis, and irritable bowel syndrome [6].
In order to exploit the full therapeutic potential of GCs,
GC/GR-mediated gene regulation and its impact on var-
ious cellular processes needs to be better understood.
To this end, we and others have studied GR-dependent
gene regulation by microarray-based transcriptional pro-
filing [7-9]. A subset of genes were identified as those
being upregulated selectively in human leukemic CEM
cells susceptible to, but not in cells refractory to, GC-
evoked apoptosis [7]. In this report, one of those genes,
E4BP4, was evaluated for its role GC-evoked apoptosis.
E4BP4 (adenovirus E4 binding protein 4), also called
NFIL3 (nuclear factor, interleukin 3 regulated) is classi-
fied as a mammalian basic leucine zipper (bZIP) tran-
scription factor and is closely related to the PAR
(proline and acid rich) sub-family of bZIP transcription
factors, although it lacks a PAR domain [10]. Vertebrate
PAR family transcription factors include hepatic leuke-
mia factor (HLF), D-box binding protein (DBP), and
thyrotroph embryonic factor (TEF) [11]. While other
PAR family members activate transcription, E4BP4
represses transcription by binding to the same DNA
sequence (E4BP4 response element; EBPRE), whose con-
sensus sequence is (G/A)T(G/T)A(C/T) GTAA (C/T)
[10]. The repressing activity of E4BP4 has been attribu-
ted to a small 65 amino acid C-terminal repression
domain that is rich in charged residues [10,12]. There
are instances where it activates transcription of target
genes as well [11].
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Ces-2 [13], D. melanogaster Vrille [14], and X. laevis
Gene8 and Gene9 [15], which are known to have crucial
functions in apoptosis, morphogenesis, and tail resorp-
tion. E4BP4 has been implicated in diverse functions,
including regulation of circadian rhythms [16], osteo-
blast function [17], motoneuron survival [18], protection
of B cells from apoptosis induced by IL-3 deprivation
[19], IgE class switching [20], and NK cell development
[21]. Interestingly, E4BP4 has been shown to exhibit
both pro-apoptotic and pro-survival functions in a cell-
and stimulus-specific fashion. For example, IL-3-
mediated survival of pro-B cells is facilitated by the
upregulation of E4BP4 [19], while the antitumor proper-
ties of cantharidin have been attributed to its ability to
upregulate E4BP4 and inhibit the antiapoptotic proper-
ties of HLF [22]. Owing to its repressive activity, E4BP4
has been suggested to function as an antagonist to other
PAR family transcription factors, which compete to bind
to the same DNA sequences [23].
E4BP4 has been shown to bind the TBP-binding
repressor protein Dr1 and facilitate its ability to repress
both basal and activated transcription [24]. There is evi-
dence that PAR proteins follow a pathway analogous to
their ortholog in C. elegans,C e s - 2 ,w h i c hi sk n o w nt o
down regulate the survival gene Ces-1, which subse-
quently permits the upregulation of the proapoptotic
gene Egl-1 [13,25,26]. PAR family proteins, including
E4BP4, have been shown to modulate the activity of
Egl-1 orthologs, the pro-apoptotic BH-3 only members
of the Bcl-2 family, either directly or via Ces-1 orthologs
Slug and Snail [27,28].
BH3-only proteins of the Bcl-2 family, Bim and Puma,
are required for the initiation of apoptosis by multiple
stimuli, including g-radiation, oxidative stress and GCs
[29-31]. Bim is required for negative selection of T cells
and B cells, and for termination of T cell immune
response [32]. Puma has been identified as a p53-induci-
ble gene and is thought to be critical for DNA-damage
induced apoptosis [33]. In CEM cells, induction of Bim
is essential for GC-evoked apoptosis, and was one of the
genes identified through microarray-based expression
profiling, along with E4BP4, as being selectively upregu-
lated in response to GCs in the GC-sensitive sister sub-
clones of CEM cells [7]. In this report, we present
evidence that E4BP4 plays a crucial role in GC-evoked
apoptosis of CEM cells by enabling induction of Bim.
Results
Previous work has demonstrated the sensitivity and
resistance of CEM-C7-14 and CEM-C1-15 cells, respec-
tively, to GC-evoked cell death via apoptosis [7]. The
resistance in CEM-C-15 cells is thought to occur
because of a blunted GR-dependent transcriptional
response, hence several studies have focused on identify-
ing key transcriptional changes that are unique to GC-
sensitive CEM cell clones [7-9]. E4BP4 was identified as
one of the key genes upregulated in correlation with
GC-evoked apoptosis [7] only in GC-sensitive CEM
lines through microarray-based expression profiling. To
investigate the role of E4BP4 in GC-evoked apoptosis,
CEM cells were manipulated either to overexpress
(CEM-C1-15) or knockdown (CEM-C7-14) E4BP4.
Creation of a clone of CEM-C1-15 cells expressing mouse
E4BP4 transcript
The mouse and human E4BP4 genes are highly homolo-
gous, with 79% nucleotide sequence identity in the cod-
ing region. The two proteins are 462 amino acids long
and have an 84% sequence identity and 92% sequence
homology, based on a BLASTP pairwise sequence align-
ment algorithm. To determine whether a lack of E4BP4
upregulation was contributing to GC resistance in
CEM-C1-15 cells, a construct expressing M. E4BP4
(pCR3.1-mE4) was transfected into CEM-C1-15 cells,
allowing for selective amplification of either the human
or mouse transcript using species-specific primers.
Although both proteins are almost identical, we cannot
rule out the possibility that the mouse protein may have
unique characteristics compared to the human version.
For both species, the entire coding sequence of E4BP4 is
within a single exon. As shown in Figure 1A, regions of
sequence variation within the partial coding sequence
shown were utilized to design PCR primers for species-
specific amplification, and mouse (376bp) and human
(250bp) specific amplicons were identified based on
their sizes. As shown in Figure 1B, the mE4BP4 primers
failed to amplify any product from CEM-C7-14 or
CEM-C1-15 cells (top panel), whereas the hE4BP4 pri-
mers failed to amplify any product when the plasmid
pCR3.1-mE4 was used as a template (bottom panel). As
shown in Figure 1C, upper panel, two batches of mass
cultures of M. E4BP4 transfected CEM-C1-15 cells
(mE*a and mE*b) as well as four different clones gener-
ated by limiting dilution were tested for presence of
transcript corresponding to mouse E4BP4 sequences.
Except for clone 2 (mE#2), the mass cultures and all
clones had amplicons corresponding to M. E4BP4 tran-
script. Clone #3 (mE#3) was chosen for further analysis,
and as shown in Figure 1C, lower panel, it exhibited
both mouse and human specific E4BP4 transcript by
reverse transcription PCR analysis.
Transfection of M. E4BP4 in CEM-C1-15 cells restores
sensitivity to Dex-evoked apoptosis
Parental CEM-C1-15 cells, mass cultures of cells trans-
fected with M.E4BP4 (CEM-C1-15mE*), and clone # 3
(CEM-C1-15-mE#3) were tested for their sensitivity to 1
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Page 2 of 13Figure 1 Primer Specificity for human and mouse E4BP4 and generation of M.E4BP4 expressing CEM C1-15mE#3 cells: Panel A:
Sequence alignment of partial mouse and human E4BP4 coding sequences within exon 2 (numbering is based on +1 for the first nucleotide of
the coding region). Upper rows indicate mouse E4BP4 sequence in upper case and lower rows show human E4BP4 sequence in lower case.
Forward and reverse primers are underlined with solid and dotted lines respectively (mE4BP4 = 742/1117 and hE4BP4 = 742/991). Panel B: The
top gel shows specificity of mE4BP4 primers for M. E4BP4 template. PCR using DNA extracted from human CEM clones failed to amplify any
product. The positive control template of plasmid pCR3.1-mE4 amplified a 376bp fragment. For the lower gel, 1:100 and 1:1000 dilutions of the
plasmid DNA pCR 3.1-mE4BP4 were subjected to qRT-PCR analysis using primers mE4BP4 (742/1117) and hE4BP4 (742/991). Product amplification
was observed only with mE4BP4 (742/1117). Panel C: CEM-C1-15 cells electroporated with 13.5 μg of linearized pCR3.1-mE4 plasmid expressing
M. E4BP4 were selected in the presence of 400 μg/ml Geneticin. Seven micrograms of total RNA extracted from two mass culture populations
(mE*a and mE*b) and four clones (mE#1-mE#4) obtained by limiting dilution was subjected to reverse transcription followed by end-point PCR
analysis for the expression of M. E4BP4 (top gel). The clone labeled mE#3 (CEM C1-15 mE#3) (circled) was used for further analysis. Lower gel
shows PCR products obtained with both mE4BP4 (742/1117) and hE4BP4 (742/991) primers using reverse transcription products from clone
mE#3, parental CEM-C1-15 and CEM C7-14 cells as the template.
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expected, CEM-C1-15 cells were resistant to Dex
induced cytotoxicity, while CEM-C1-15mE* cells showed
a slight reduction (18%) in viable cell number after 68h
in 1 μM Dex (Figure 2A). The cloned line, CEM-C1-15-
mE#3, exhibited Dex-evoked sensitivity similar to the
sensitive CEM-C7-14 cells, with viable cell numbers
after 72h in 1 μM Dex being less than 5% of the corre-
sponding ethanol treated cells (Figure 2B). To test
whether Dex activated apoptosis in CEM-C1-15-mE#3
cells, lyastes of cells treated with ethanol or 100nM Dex
were analyzed for PARP cleavage by Western blotting
using an anti-PARP antibody that recognizes both the
intact protein (116kDa) and the cleaved C-terminal por-
tion (85kDa). After 48h in 100nM Dex, parental CEM-
C1-15 cells showed no significant accumulation of the
cleaved 85kDa band, while the CEM-C1-15-mE#3 cells
showed a majority of PARP as the 85kDa band, suggest-
ing caspase-dependent cleavage, and hence activation of
apoptosis. All three lines were subjected to cytogenetic
analysis. Previous data suggests that a key difference
between the two sister clones is that CEM-C7-14 cells
bear a t(1;2)(p13;q21) translocation, while the CEM-C1-
15 cells do not [7]. Karyotype analysis (data not shown)
confirmed that CEM-C1-15mE#3 cells and parental
CEM-C1-15 cells had normal chromosomes 1 and 2,
while CEM-C7-14 cells had the translocation. These
data ruled out the possibility the CEM-C1-15-mE#3
cells were a population of CEM-C7-14 cells inadver-
tently mixed with the CEM-C1-15 cells that were trans-
fected with M.E4BP4, and reiterating that transfection of
M.E4BP4 may have contributed to the responsiveness of
CEM-C1-15mE#3 cells to Dex-induced cell death.
Accumulation of cells in sub-G1 phase in response to Dex
DNA content was measured by flow cytometric analysis
of propidium iodide stained cells at 24, 48 and 72 h
after treatment with either ethanol or 1 μM Dex (Figure
3). Accumulation of cells with sub-G1 DNA content
was apparent after 48 h in Dex. In CEM-C7-14 and
CEM-C1-15mE#3 cells, exposure to 1 μMD e xf o r4 8h
resulted in approximately 38% and 73% of the cells with
DNA content in the sub-G1 range, respectively, while
cells treated with ethanol had only 15% and 20% of the
cells with sub-G1 DNA content. Exposure to 1 μMD e x
for 72 h shifted 68% and 85% of CEM-C7-14 and CEM-
C1-15mE#3 cells to sub-G1 phase, respectively. In GC-
resistant CEM-C1-15 cells only moderate changes in
sub-G1 cell accumulation were observed, with 14% and
22% of cells in sub G1 phase after 72 h in ethanol and 1
μM Dex, respectively. It is interesting to note that the
CEM-C1-15mE#3 cells appear more sensitive to Dex
than the CEM-C7-14 cells, which correlates to the
results observed in a Dex titration viability assay (data
not shown).
GC-dependent upregulation of Bim is restored in CEM-C1-
15mE#3 cells
Upregulation of Bim [34] and Puma [31] have been
implicated in Dex-evoked apoptosis of CEM-C7-14 and
other lymphoid cells. In GC-sensitive CEM-C7-14 cell,
Bim upregulation has been shown to contribute to
apoptosis, while in GC-resistant CEM-C1-15 cells, GCs
A
B
Hours in
100nM Dex
C
116
85
CEM C1-15 CEM C1-15-mE#3
00 24 24 48 48
PARP
Figure 2 Dex induces apoptosis in CEM C1-15 cells transfected
with M. E4BP4: Panel A:CEM C1-15 and a mass culture CEM C1-15
cells (CEM C1-15mE*) transfected with the mouse E4BP4 expressing
construct pCR3.1-mE4 were seeded at a density of 1 × 10
5cells/ml
and treated for 72 h with either 0.1% ethanol (EtOH) or 1 μM Dex.
Aliquots were taken at 24 h intervals and viable cell number was
determined by trypan blue dye exclusion assay. Data represent
average ± S.D. of three independent experiments with two
replicates each. Panel B:A clone of CEM C1-15mE* with confirmed
expression of mE4BP4 (CEM C1-15mE#3), and parental CEM C1-15
and CEM C7-14 cells were analyzed for cell viability in the presence
of 0.1% ethanol or 1 μM Dex as in Panel A. Data represent averages
± S.D. of three separate experiments with two replicates each.
Panel C: CEM C1-15 or CEM C1-15mE#3 cells treated for 48 h with
100 nM Dex and cell lysates were prepared from aliquots harvested
every 24 h. Protein content of lysates was determined by the
Bradford assay and 30 μg total protein from each sample was
evaluated for PARP cleavage by Western blotting using a C-
terminal-specific anti-PARP antibody (SC-7150, Santa Cruz
Biotechnology).
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Page 4 of 13do not upregulate either Bim or Puma. To determine
whether restoration of GC-induced apoptosis in CEM-
C1-15mE#3 cells correlated with restoration of Bim
upregulation, all three CEM lines were treated with
either ethanol or 1 μM Dex for 24 h and analyzed for
Bim and Puma transcript levels by reverse transcription
followed by RT-qPCR, as detailed in the methods sec-
tion. As reported previously, CEM-C7-14 cells
responded to Dex by almost a 9.5-fold induction of Bim
expression, while in CEM-C1-15 cells, no significant
induction was observed. In CEM-C1-15mE#3 cells, Bim
transcript levels were induced by over 7-fold in the pre-
sence of 1 μMD e x( F i g u r e4 A ) .P u m ae x p r e s s i o nw a s
not significantly affected by Dex in any of the cell lines
tested. Bim protein levels were evaluated by Western
blotting using an antibody that recognizes all three
isoforms of Bim: BimEL, BimL and BimS. As seen in
Figure 4B, both CEM-C7-14 and CEM-C1-15mE#3 cells
showed Dex-dependent induction of BimEL and BimS
protein levels, while CEM-C1-15 cells were non-respon-
sive. Interestingly, CEM-C1-15mE#3 cells showed a
markedly higher fold-induction based on band intensity,
which correlates with the greater sensitivity of these
cells to Dex-evoked accumulation of cells in Sub-G1
phase (Figure 3A).
GC-mediated E4BP4 upregulation is restored in CEM-C1-
15mE#3 cells
Since E4BP4 seems to be a key transcriptional regulator
that may alter expression of several genes involved in
GC-mediated apoptosis, changes in E4BP4 transcript
levels were also measured in all three cell lines in
Statistical  Significance : Paired Student’s T-Test
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C7-14 vs. 
C1-15
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C7-14 vs. 
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Figure 3 Flow cytometric cell cycle analysis demonstrates sub-G1 accumulation of CEM C1-15mE#3 cells treated with Dex: CEM C7-14,
CEM C1-15 and CEM C1-15mE#3 cells were treated with 0.1% ethanol (EtOH) or 1 μM Dex for 24, 48 and 72 h, stained in propidium iodide, and
analyzed for cell cycle distribution flow cytometrically using an Accuri C6 flow cytometer and CFlow
® software. Panel A: Representative
histograms of cell cycle distribution of ethanol and Dex treated cells after 72 h treatment. For each analysis 50,000 singlet cells were gated into
sub-G1, G1, S and G2/M as indicated for the top left histogram. Panel B: Time course of accumulation of cells with sub-G1 DNA content as a
percentage of total cells analyzed. Average ± S.D. from three independent experiments. Panel C: Data from three independent experiments
were subjected to a paired Student’s T-test (two sample, equal variance). Gray shaded boxes represent significant differences with p-values <
0.05.
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Page 5 of 13response to 1 μM Dex. As expected, CEM-C7-14 cells
showed a 8.4-fold induction of E4BP4 transcript levels,
while CEM-C1-15 cells showed a minimal 2-fold
increase (Figure 4C). Unexpectedly, in CEM-C1-15mE#3
cells, Dex induced a 7.5-fold increase in E4BP4 expres-
sion (Figure 4C). Since the primers used were specific
for H. E4BP4 and do not detect the transfected M.
E4BP4 (Figure 1B), these data demonstrate that transfec-
tion of M. E4BP4 somehow facilitates GR-dependent
transcriptional regulation of endogenous E4BP4. These
data emphasize the importance of E4BP4 regulation in
GC-evoked apoptosis. In Western blotting experiments
using two different E4BP4-specific antibodies that recog-
nize both the mouse and human homologs, it is clear
that E4BP4 protein levels are not affected by Dex in
CEM-C1-15 cells, but are induced in CEM-C7-14 and
CEM-C1-15mE#3 cells (Figure 4D). Since basal E4BP4
protein levels are high in CEM-C1-15 cells compared to
CEM-C7-14 cells (top panel, Figure 4D), transfection of
M. E4BP4 did not significantly alter total protein abun-
dance in EtOH treated samples, however, introduction
of M.E4BP4 restored Dex-dependent induction of
E4BP4 protein (2-3 fold in different experiments). Our
data suggest that in CEM-C1-15 cells, E4BP4 protein
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Figure 4 Dex-mediated upregulation of Bim and E4BP4 is restored in CEM C1-15mE#3 cells: Panels A and C: CEM C7-14, CEM C1-15 and
CEM C1-15mE#3 cells were treated with 0.1% ethanol or 1 μM Dex for 24 h and total RNA was extracted in TriZol. Seven microgram RNA was
subjected to reverse transcription reaction and real-time qPCR using primers specific for Bim or Puma (Panel A) or E4BP4 (Panel C) as listed in
Table 1. Fold change in expression of each transcript by 1 μM Dex was calculated by the Pfaffl method using b-actin as a reference. Data
represent averages ± S.D. from three independent experiments, which were analyzed for statistical significance using a paired student t-test, as
shown in the table below each bar chart. Shaded boxes represent significant differences with p-values ≤ 0.05. Panels B and D: CEM C7-14, CEM
C1-15 and CEM C1-15mE#3 cells were treated with 0.1% ethanol (E) or 100 nM Dex (D) for 24 h and total protein was extracted in lysis buffer.
Protein content of lysates was measured by the Bradford assay, and 30 μg protein from each sample was evaluated by Western blotting for Bim
and Puma expression (Panel B) or for E4BP4 expression using two different antibodies from Santa Cruz Biotechnology (Panel D). An antibody for
GAPDH was used as a reference.
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Page 6 of 13levels are deregulated, and that regulation is restored
upon M. E4BP4 transfection.
Dex-mediated effects in CEM C1-15mE#3 cells are GR-
dependent
To confirm that Dex-dependent cell death and E4BP4
and Bim upregulation are dependent on GR, the effects
of the GR antagonist RU 38486 (RU486) on cell viability
and induction of transcription were monitored. RU486
blunted Dex-evoked loss of cell viability (Figure 5A),
and prevented Dex-mediated upregulation of H.E4BP4
and Bim transcripts (Figure 5B).
shRNA-mediated E4BP4 knockdown shows correlation
between E4BP4 and Bim expression
It is noteworthy that GC-resistant CEM-C1-15 cells
express abundant basal E4BP4 transcript and protein,
but fail to respond to GCs by upregulating either E4BP4
or Bim. To determine the effect of E4BP4 knockdown
on Bim expression and sensitivity to GCs, CEM-C7-14
cells stably transfected with three different E4BP4-speci-
fic shRNA plasmids, ID1, ID2 and ID4, were created. As
shown in Figure 6A, two of these cell populations, ID2
and ID4 showed about 25% knockdown in the basal
(ethanol treated) state, when compared to the parental
CEM-C7-14 cells, while ID1 showed marginally higher
E4BP4 expression than CEM-C7-14 cells. This pattern
closely correlated with the extent of basal Bim expres-
sion, with both ID2 and ID4 showing 33 to 25% reduc-
tion in basal expression compared to CEM-C7-14 cells,
and ID1 showing a marginal increase in Bim expression
compared to parental cells. Similarly, when E4BP4 tran-
script levels were compared in Dex-treated cells, ID2
and ID4 showed 12% and 27% reduction, respectively,
when compared to CEM-C7-14 cells, while ID1 showed
no change (Figure 6B). In correlation, Bim transcript
levels were 8% and 30% reduced in ID2 and ID4 cells,
when compared to CEM-C7-14 cells, in response to
Dex, and ID1 did not show any change. Thus, although
the extent of knockdown achieved was poor, the data
demonstrated a clear correlation between E4BP4 and
Bim expression, with correlation coefficients greater
than 0.995 in both ethanol and Dex treated groups.
Based on E4BP4 expression levels in parental CEM-C7-
14 and CEM-C1-15 cells, it is apparent that rather than
absolute abundance of E4BP4 and Bim transcripts, the
change in expression in response to Dex determines
sensitivity. Thus, each of the shRNA transfected cell
populations, and CEM-C7-14 cells were also evaluated
for their ability to upregulate E4BP4 and Bim expression
in response to 1 μMD e x .A ss h o w ni nF i g u r e6 C ,a l l
cell populations, including the knockdowns, showed a
4.5 to 7.5-fold upregulation of H. E4BP4 expression in
response to Dex treatment, with a parallel 5.6 to 9.4-
fold Dex-induced upregulation of Bim expression.
Remarkably, ID2 cells showed a greater increase in
E4BP4 and Bim expression compared to CEM-C7-14
cells. The E4BP4 knockdown cells were evaluated for
their viability in the presence of 1 μM Dex (Figure 6D),
and all cells were susceptible to Dex-evoked cell death,
comparable to CEM-C7-14 cells. Interestingly, ID2 cells,
which showed the maximum fold induction of E4BP4
and Bim expression, also showed the greatest sensitivity
to Dex-evoked cell death, confirming the correlation
between E4BP4/Bim inducibility and susceptibility to
cell death.
Discussion
GCs are essential components of various therapeutic
regimens because of their immunosuppressive and lym-
phoid cell apoptosis-inducing properties [35]. GC-
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Figure 5 RU38486 blocks Dex-mediated effects in CEM C1-
15mE#3 cells : Panel A: CEM C1-15mE#3 cells were seeded at a
density of 1 × 10
5cells/ml and treated for 72 h with either 0.1%
ethanol (EtOH), 1 μM Dex, 1 μM RU486, or both Dex and RU486.
Trypan blue excluding viable cells were counted at 24h intervals.
Data represent averages ± SD from triplicate sets of treatments
from two experiments. Panel B: CEM C1-15mE#3 cells were treated
as in Panel A for 24h and RNA was extracted with TriZol. RNA was
subjected to reverse transcription reaction and real-time qPCR using
primers specific for Bim or Puma as described for Figure 4. Fold
change in expression was calculated by the Pfaffl method using b-
actin as a reference. Data represent averages ± SD from two
independent experiments run in duplicates.
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dependent transcriptional regulation of key pro- and
anti-apoptotic genes [36-38]. Previous studies have
established E4BP4 as one of approximately forty genes
that are upregulated following Dex exposure in the GC-
sensitive CEM-C7-14 subclone [7]. E4BP4 is a ‘delayed-
early-response’ gene which is upregulated by several sti-
muli, including IL-3 [39], IL-4 [40], calcium [41,42],
cAMP [43], and GCs [44], and is a known transcrip-
tional repressor with homology to the C. elegans pro-
apoptotic ces-2 gene and the mammalian PAR family
genes [11,18].
The PAR family proteins have distinct functions in
cell survival and apoptosis, and E4BP4 has been
reported to be a survival factor for pro-B cells [19], car-
diomyocytes [45], and motoneuron cells [18]. In con-
trast, E4BP4 expression is upregulated by the tumor
suppressor PTEN, and is suppressed in ovarian cancers
[46], suggesting that it is a pro-apoptotic factor. Indeed,
our data suggests that E4BP4 is a proapoptotic factor in
T-lymphoid leukemic cells, because expression of ecto-
pic M.E4BP4 sensitizes CEM-C1-15 cells to GC-evoked
apoptosis. It has been previously established that CEM-
C7-14 and CEM-C1-15 cells possess approximately
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Figure 6 shRNA based variable knockdown of E4BP4 correlates with corresponding repression of Bim expression: CEM C7-14 cells were
transfected with three different E4BP4 shRNA plasmidsID1, ID2 and ID4 with a puromycin selection marker. Transfected cells were selected in
the presence of 1 μg/ml puromycin, and surviving cells were analyzed for extent of E4BP4 knockdown and Bim expression in comparison to
untransfected cells. Cells were treated with 0.1% ethanol or 1 μM Dex for 24h and total RNA was extracted in TriZol. Seven microgram RNA was
subjected to reverse transcription reaction and real-time qPCR using primers specific for E4BP4 or Bim as listed in Table 1. Fold change in
expression in knockdown cells (ID1, ID2 or ID4), compared to CEM C7-14 cells, for ethanol treated (Panel A) and Dex treated (Panel B) cells was
calculated by the Pfaffl formula: (Etarget)
ΔCTtarget/(Eref)
ΔCTref where ΔCTtarget = (CTCEM C7-14-CTID) for E4BP4 or Bim and ΔCTref = (CTCEM C7-14-CTID)
for b-actin. Induction of E4BP4 or Bim expression in response to 1 μM Dex was calculated for CEM C7-14, ID1, ID2, and ID4, by the Pfaffl method,
whereΔCTtarget = (CTethanol-CTDex) for E4BP4 or Bim and ΔCTref = (CTethanol-CTDex) for b-actin (Panel C). Efficiency for each reaction was
calculated using the software LinRegPCR. Data represent averages ± S.D. from three independent experiments. Correlation between E4BP4 and
Bim expression was determined by calculating the correlation coefficients (r) which are indicated on each panel. Panel D: CEM C7-14 and mass
cultures of cells transfected with ID1, ID2 and ID4 shRNA plasmids against E4BP4, and selected with puromycin were seeded at a density of 1 ×
10
5cells/ml and treated for 96 h with either 0.1% ethanol (EtOH) or 1 μM Dex. Aliquots were taken at 24 h intervals and viable cell number was
determined by trypan blue dye exclusion assay. Data represent average ± S.D. of three independent experiments with two replicates each.
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Page 8 of 13equal numbers of GR sites per cell, however, CEM-C1-
15 cells possess a lower binding affinity between GCs
and the GR than CEM-C7-14 cells, and a blunted GR-
dependent transcriptional response [47]. E4BP4 may sta-
bilize the GC-GR transcription complex, and ectopic
E4BP4 expression may restore GR-dependent transcrip-
tion and therefore reestablish GC sensitivity in CEM-
C1-15mE#3 cells. Human E4BP4 expression was signifi-
cantly induced in CEM-C1-15mE#3 cells following Dex
exposure, with levels comparable to the induction
observed in CEM-C7-14 cells, suggesting that E4BP4
may be involved in an autoregulatory loop, with ectopic
expression of the mouse gene restoring regulation of the
endogenous gene. When CEM-C7-14 cells were trans-
fected with E4BP4 shRNA, upto 25% knockdown of
basal and Dex-induced E4BP4 expression, over parental
CEM-C7-14 cells was achieved. However, the fold-
induction in the presence of Dex (comparing basal and
Dex-induced expression within each knockdown group)
was comparable to parental CEM-C7-14 cells, explaining
why shRNA-mediated knockdown did not cause CEM-
C7-14 cells to become refractory to Dex-evoked apopto-
sis. Two lines of evidence indicate that CEM-C1-
15mE#3 cells are truly derived from CEM-C1-15 cells:
karyotype analysis and PCR-array-based transcriptional
profiling both suggest these cells to be distinct from
CEM-C7-14 cells and related to CEM-C1-15 cells (data
not shown).
Upregulation of Bim is requir e df o rD e x - i n d u c e dc e l l
death in CCRF-CEM cells. Knockdown of Bim expres-
sion by shRNA gene silencing strongly reduced cell
death in response to Dex treatment [48]. In data pre-
sented here, Dex-mediated Bim induction was restored
in CEM-C1-15mE#3 cells in conjunction with their sen-
sitization to Dex-evoked apoptosis upon expression of
ectopic M. E4BP4. These data suggest that Bim expres-
sion may be regulated by E4BP4, or that ectopic E4BP4
enables GR-dependent transcriptional responses, which
include Bim upregulation. In CEM-C7-14 cells trans-
fected with E4BP4 shRNA, reduction of basal or Dex-
induced E4BP4 expression (when compared to similarly
treated parental CEM-C7-14 cells) by about 25%, corre-
lated with a parallel reduction in basal and Dex-induced
Bim expression by about 30%, strongly suggesting that
Bim is a downstream target of E4BP4-mediated tran-
scriptional regulation. Within each knockdown group,
the fold-induction in Bim expression after Dex treat-
ment (comparing basal to Dex-induced expression) was
similar to parental CEM-C7-14 cells, hence there was
minimal effect on cell viability. These data suggest that
the relative change in expression, rather than the abso-
lute amount of expression, of E4BP4 and Bim determine
sensitivity to GC-evoked apoptosis. Promoter analysis of
Bim did not indicate the presence of an EBPRE or GRE,
which suggests E4BP4 or GR do not directly regulate
Bim expression. However, E4BP4 could regulate Bim
expression through a yet to be determined intermediate,
or through the formation of a ternary complex with
another transcription factor on the Bim promoter.
Recent studies have proposed that PAR bZIP proteins
have a role in the transcriptional control of BH3-only
proapoptotic genes. Benito et al. showed that promoter
for bcl-gs (a BH3-only gene) is responsive to TEF activa-
tion and is silenced by E4BP4 in human tumor cells
[28,49].
E4BP4 has been shown to induce differentiation in
monocyte-macrophages [50], to drive natural killer cell
lineage development [51] and to regulate IgE class-
switching [20], all important immunological responses.
E4BP4 has also been shown to antagonize the function
of other PAR family proteins, namely, HLF, TEF and
DBP, owing to the presence of a repressor domain in
E4BP4 competing for the same or similar DNA binding
sequences [23,52]. Studies have implicated HLF and
TEF as antiapoptotic factors [53,54], and leukemic stem
cells have been shown to consistently overexpress HLF
[55,56]. Moreover, microarray profiling has identified
HLF as a “stemness” gene in hematopoietic stem cells
[57,58]. E4BP4, by virtue of its ability to antagonize
HLF, has been suggested to regulate the anti-apoptotic
properties of HLF [23,59]. In fact, cantharidins, a class
of potential anti-tumor agents, are thought to induce
apoptosis by E4BP4-mediated inhibition of the antiapop-
totic activity of HLF [55]. It is possible that HLF and
other PAR family proteins play an important role in
CEM cell apoptosis, and that the ratio of E4BP4 and
other PAR proteins regulates the apoptotic state of
these cells.
Conclusions
Studies presented here strongly suggest an important
role for E4BP4 in leukemic T-cell apoptosis through
activation of the Bim pathway. E4BP4 may modulate
GR-dependent transcription, either by binding directly
to GR, or to one of its coregulatory factors. Alterna-
tively, E4BP4 may activate a repression pathway, such
that it may repress a negative regulator of Bim, facilitat-
ing enhanced Bim transcription.
Methods
Reagents
Dexamethasone (Dex) was purchased from EMD Bios-
ciences (Madison, WI). The GR antagonist RU38486
was a gift from Dr. E. Brad Thompson (UTMB, Galves-
ton, TX). Reagents for reverse transcription (RT) and
Real-time qPCR, including M-MLV reverse transcrip-
tase, oligo(dT)15 primer, RNasin
®Ribonuclease inhibitor,
dNTP mix, and Taq DNA polymerase were purchased
Beach et al. Journal of Molecular Signaling 2011, 6:13
http://www.jmolecularsignaling.com/content/6/1/13
Page 9 of 13from Promega Life Sciences (Madison, WI). SYBR
®-
JumpStart™TaqReadyMix was from Sigma-Aldrich (St.
Louis, MO). Other reagent grade chemicals were pur-
chased from Fisher Scientific (Pittsburgh, PA) or Sigma-
Aldrich.
Cell culture and treatments
The CCRF-CEM [60] derived human T-ALL cell lines
CEM C7-14 and CEM C1-15 are sensitive and resistant
to GCs, respectively, and are generous gifts from Dr. E.
B. Thompson, University of Texas Medical Branch, Gal-
veston. The cells were cultured in RPMI 1640 (with L-
glutamine) from Cellgro(Manassas, VA, Catalog #50-
020-PB) supplemented with 5% heat-inactivated fetal
bovine serum (FBS) from Atlanta Biologicals (Lawrence-
ville, GA, Cat #S11150). Cells were maintained in log
phase at 37°C in a 5% CO2 incubator. Cell treatments
were for 24 to 96 h in RPMI supplemented with 5% FBS
containing either 100 nM or 1 μM Dex (diluted from a
1000x stock in ethanol) or 0.1% ethanol as vehicle alone.
Estimation of cell viability
Cells were plated at a density of 1 × 10
5 cells/ml and
treated for 96 h with 0.1% ethanol or 1 μM Dex diluted
from a 1000x stock prepared in ethanol. Aliquots were
removed at 24 h intervals for cell counts. Viable cells
were counted by the trypan blue exclusion method
using a Hemocytometer.
Primer design
Mouse (GenBank accession # NM_017373) and human
(accession # NM_005384) E4BP4 cDNA sequences were
aligned to identify regions of maximum mismatch (Fig-
ure 1A). Species-specific forward primers from the same
region (starting at nucleotide 742) and staggered reverse
primers were designed to allow for amplicons of 376bp
and 250bp for mouse- and human-specific PCR pro-
ducts, respectively, as indicated in Figure 1A. Primer
specificity was confirmed as indicated in Figure 1B. The
three isoforms of human Bim: BimS, BimL, and BimEL,
differ in amino acid length, but all possess the charac-
teristic BH3 domain within exon five. The Bim primers
were designed across exons five and six to detect and
amplify all three transcripts concurrently. These and
additional primers used for quantitation of Puma and b-
actin are listed in Table 1.
Transfection of M. E4BP4
The M. E4BP4 expressing construct pCR 3.1-mE4BP4
(generous gift from Dr. Sotirios Tetradis, UCLA) was
linearized with Sca I and resuspended 10 mM TrisHCl,
pH 8.0. Logarithmic phase CEM C1-15 cells were resus-
pended in 400 μl of serum free RPMI to a final density
of 5 × 10
6 cells/ml, mixed with 13.5 μgo fl i n e a r i z e d
pCR 3.1-mE4BP4, andelectroporated at 1050 μF and 260
volts in the BioRad Gene Pulser II. Following electro-
poration, the cells were allowed to recover for 48 h in 2
ml of pre-warmed RPMI media, supplemented with 5%
FBS. Transfected cells were selected in 400 μg/ml
Geneticin, and a preliminary analysis of surviving cells
revealed presence of mouse E4BP4-specific transcript
(Figure 1C). This mass culture was cloned by limiting
dilution to establish multiple clonal lines of CEM C1-15
cells expressing M. E4BP4. The clonal line CEM C1-
15mE#3 was used for further analysis.
Reverse transcription and RT-qPCR (real-time-quantitative
PCR) analysis
Cells were treated at a density of 4 × 10
5 cells/ml for 24
h with either ethanol or Dex, and RNA was extracted
from approximately 1 × 10
7 cells using the TRIzol
reagent (Invitrogen Life Technologies, La Jolla, CA). For
first-strand DNA synthesis, 7 μg of total RNA was
reverse transcribed for 3 h at 42°C in the presence of
0.5 μg of oligo(dT)15,1μl (~200 U) of M-MLV reverse
transcriptase, 0.5 mM dNTP mix, and 100 U of RNase
inhibitor. For RT-qPCR, 1 μl of the reverse transcription
product was mixed with SYBR
® Green JumpStart™ Taq
Ready Mix(Sigma-Aldrich, Cat #4438) and the appropri-
ate primers (Table 1) in a final volume of 25 μl, and run
Table 1 Primers used for PCR
Transcript
(Primer Name)
Forward Primer Reverse Primer Product Size
H. E4BP4
(HUMANE4BP4-742 & 991)
5’ATGGGGAATTCTTTCTCTGG3’ 5’CTTTGATCCGGAGCTTGTGT3’ 250 bp
M. E4BP4
(Mouse E4BP4-742 &1117)
5’ATGGGAAGCTCTTTCTCCACT3’ 5’TACCCGAGGTTCCATGTTTC3’ 376 bp
Bim
(BIM 5/6 SENSE & ANTI)
5’CAGATATGCGCCCAGAGATA3’ 5’ACCAGGCGGACAATGTAAC3’ 163 bp
Puma
(PUMA SENSE & ANTI)
5’AAGAGCAAATGAGCCAAACG3’ 5’GCAGAGCACAGGATTCACAG3’ 181 bp
b-actin
(B-ACTIN-130 SENSE & ANTI)
5’AGTCCTCTCCCAAGTCCACA3’ 5’CACGAAGGCTCATCATTCAA3’ 130 bp
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tate the relative expression levels, the cycle threshold
(CT) values for each sample were used to calculate fold
inductions using the Pfaffl method [61] formula: (E)
ΔCTtarget(control-sample)/(E)
ΔCTreference(control-sample),w h e r e
b-actin was the reference gene. E represents primer effi-
ciency, which was calculated for each sample reaction
using the freeware program LinRegPCR. Statistical ana-
lysis was done on Excel using a paired Student’st - t e s t ,
where p ≤ 0.05 was considered to be statistically
significant.
Analysis of Cell Cycle Distribution by Flow Cytometry
Cells were seeded at a density of 1.0 × 10
5 cells/mL in
5-25 ml of media, and treated with ethanol or 1.0 μM
Dex for 24, 48, or 72 hours prior to fixing. Cells were
washed twice in PBS, resuspended in 0.5 ml of low salt
stain (30 mg/ml PEG 6000, 25 μg/mlpropidium iodide,
0.01% Triton-X-100, and 0.01% RNase A in 4 mM
sodium citrate), and incubated at 37°C for 20 minutes.
Following incubation, 0.5 ml of high salt stain (30 mg/
ml PEG 6000, 25 μg/ml propidium iodide, 0.01% Tri-
ton-X-100, and 0.01% RNase A in 400 mM sodium
chloride) was added to the samples and mixed by gentle
vortexing. After a brief storage at 4°C, samples were
analyzed for propidium iodide staining on an Accuri C6
Flow Cytometer
®(Accuri Cytometers Inc., Ann Arbor,
MI). Data were processed using the Accuri CFlow
® soft-
ware, gating to include only single cells. Extent of propi-
dium iodide staining of the gated population was
displayed in a histogram and the following regions were
defined: sub-G1,G 1,S ,a n dG 2/M. Percentages of cells
in each region was calculated from three independent
experiments. Standard deviation and probability by Stu-
dent T-tests were calculated in Excel.
Western blotting
Cells plated at a density of 4 × 10
5 cells/ml were treated
for 24 h or 48 h with the ethanol or Dex, and approx. 8
×1 0
6 cells were harvested, washed and lysed in buffer
containing 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1%
NP-40, plus a protease inhibitor cocktail. The amount of
protein in each sample was estimated using the Bradford
assay, and 30 μg of each sample was boiled in SDS-
PAGE sample buffer (final composition: 120 mM Tris,
4% SDS, 20% glycerol, 5% 2-mercaptoethanol, 0.05%
bromophenol blue, pH 6.8) Samples were resolved on a
10% or 12.5% polyacrylamide-SDS gel, and electoblotted
on to PVDF membranes. Membranes were blocked in
10% non-fat dry milk and incubated sequentially with
appropriate primary and secondary antibodies. Polyclo-
nal antibodies (cat#s sc-9550 and sc-28203) that recog-
nize both mouse and human E4BP4, and anti-PARP
antibody (cat# sc-7150) that recognizes both the full-
length and truncated versions of the protein, were from
Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal
anti-Bim antibody (cat# 559685) which recognizes BimS,
BimL and BimEL was from BD-Pharmingen (San Diego,
CA), polyclonal anti-Puma antibody (cat# AP1317a) was
from Abgent (San Diego, CA), and polyclonal anti-
GAPDH antibody (cat# 2118) was from Cell Signaling
Technology (Beverly, MA). Secondary horseradish per-
oxidase (HRP) conjugated anti-rabbit IgG and anti-goat
IgG were from Santa Cruz Biotechnology (Santa Cruz,
CA). Membranes were developed using an Enhanced
Chemiluminescence (ECL) kit from Pierce Biotechnol-
ogy (Rockford, IL).
shRNA based E4BP4 knockdown
Five micrograms each of four pre-designed shRNA plas-
mids (ID1 to ID4) from SA Biosciences, each containing
a different short hairpin RNA (shRNA) sequence target-
ing human E4BP4, and containing a puromycin resis-
tance gene, were electroporated separately into2 × 10
6
CEM-C7-14 cells (in 250 μl) at 1050 μF and 260 volts,
using the IngenioTM Electroporation reagent (Mirus
Bio, Madison, WI). Puromycin resistant populations
from three transfectants, ID1, ID2 and ID4 could be
selected in media containing 1 μg/ml puromycin, while
ID3 transfected cells failed to survive. Efficiency of
E4BP4 knockdown in ethanol and 1 μM Dex treated
cells compared to similarly treated parental CEM C7-14
cells, and extent of Dex-dependent upregulation of
E4BP4 and Bim was determined by RT-qPCR analysis.
Data were processed from three independent experi-
ments using the Pfaffl method, as detailed in the legend
for Figure 5. To determine the relationship between
E4BP4 expression and Bim expression, correlation coef-
ficients were calculated for each set of data. Effect of
Dex on cell viability in shRNA transfected cells was
determined in three independent experiments by trypan
blue dye exclusion assay.
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